27

Apr

Pfizer, BioNTech seek U.S. authorization of COVID-19 booster shot for younger kids

Pfizer Inc  and its partner BioNTech announced that they had submitted an application to the U.S. health regulator for the authorization of a booster dose of their COVID-19 vaccine for…

Read More Here

06

Apr

Second booster shields elderly from COVID but protection wanes quickly –  Israeli study

April 6 (Reuters) - A fourth dose of the Pfizer/BioNTech vaccine lowered rates of COVID-19 among the elderly but the protection against infection appeared short-lived, a large study in Israel has found. The second…

Read More Here

31

Dec

Pfizer’s COVID-19 shot causes mostly mild side effects in young kids – U.S. CDC

Pfizer Inc and BioNTech SE's COVID-19 vaccine caused mostly mild side effects in children aged 5 to 11 years, according to data published by the U.S. Centers for Disease Control…

Read More Here

17

Dec

Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations

Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the…

Read More Here

13

Dec

FACTBOX-COVID-19 vaccine rollout for children aged 5-11 in the EU

The European Union rollout of the Pfizer and BioNTech COVID-19 vaccine for 5- to 11-year-olds should begin Dec. 13, as countries are expanding their vaccination programmes to include young children…

Read More Here

13

Dec

Two-dose vaccines induce lower antibodies against Omicron, study finds

Dec 13 (Reuters) - Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected…

Read More Here

01

Dec

UPDATED: EU launch of Pfizer/BioNTech COVID shot for younger children brought forward to Dec 13

he European Union-wide rollout of Pfizer and BioNTech's COVID-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week earlier than previously planned, Germany's health ministry said…

Read More Here

24

Oct

Vaccine combinations with different technologies may be best

Healthcare workers in France who got a first shot of AstraZeneca’s COVID-19 vaccine and then the Pfizer/BioNTech vaccine for their second shot showed stronger immune responses than those who had…

Read More Here

23

Oct

FDA says benefits outweigh risks for Pfizer/BioNTech COVID-19 vaccine in children

Scientists at the U.S. Food and Drug Administration (FDA) said on Friday that the likely benefits of giving the Pfizer/BioNTech COVID-19 vaccine to 5 to 11 year olds clearly outweigh…

Read More Here

20

Sep

Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids

Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for authorization to…

Read More Here

03

Sep

UPDATED: EU reviewing cases of rare body inflammation after COVID-19 shots

Europe's medicines regulator said on Friday it was reviewing if there was a risk of a rare inflammatory condition after inoculation with COVID-19 vaccines, following a report of one case…

Read More Here

24

Jun

Pfizer says COVID vaccine highly effective against Delta variant

The Pfizer-BioNTech vaccine is highly effective against the Delta variant of COVID-19, a Pfizer official in Israel said on Thursday. First identified in India, Delta is becoming the globally dominant…

Read More Here

20

May

UPDATED: European Commission signs third contract with BioNTech-Pfizer for 1.8 bln vaccine doses, Hungary opts out

The European Commission said on Thursday that it signed a third contract with pharmaceutical companies BioNTech SE and Pfizer Inc for an additional 1.8 billion doses of the coronavirus vaccine.…

Read More Here

07

May

UPDATED: Die Welt reports France delaying EU order for COVID-19 vaccine

France is delaying an EU order for 1.8 billion doses of the BioNTech/Pfizer COVID-19 vaccine planned for the next two years, a German newspaper said on Friday, citing EU diplomats,…

Read More Here

31

Mar

Pfizer COVID-19 vaccine safe, effective on adolescents in trial, companies say

Pfizer Inc and BioNTech SE said on Wednesday their COVID-19 vaccine was safe and effective and produced robust antibody responses in 12- to 15-year olds, paving the way for them…

Read More Here

12

Mar

Pfizer/BioNTech say COVID-19 vaccine likely to prevent asymptomatic infection

Pfizer Inc and BioNTech SE said that real-world data from Israel suggests that their COVID-19 vaccine is 94% effective in preventing asymptomatic infections, meaning the vaccine could significantly reduce transmission.…

Read More Here

25

Feb

Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial

Pfizer Inc and BioNTech SE said on Thursday they are testing a third dose of their COVID-19 vaccine to better understand the immune response against new variants of the virus.…

Read More Here

23

Jan

French health body recommends delaying second COVID shot to six weeks after first

France's top health advisory body on Saturday recommended doubling the time between people being given the first and second COVID-19 vaccinations to six weeks from three in order to increase…

Read More Here